Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Androgen levels are more linked to body size in boys than girls.

Higher levels of 3α-diol G are linked to more severe female pattern hair loss.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Some off-label treatments may be effective for male pattern baldness.

Hair loss is mainly caused by hormones, autoimmune issues, and chemotherapy, and needs more research for treatments.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Dermatologists in Spain now mostly prescribe oral minoxidil and dutasteride for hair loss.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

High-dose androgen therapy can help manage certain types of androgen resistance.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Androgenetic alopecia is complex and needs more research for better treatments.

A man's baldness improved possibly due to a medication that blocks male hormones.

Mouse genital development depends on male or female hormones for specific features.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Gene variation affects prostate issues and hair loss.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

There are many treatments for common hair loss, but more trials are needed to decide which are best.